Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parikh

Showing results (391-400 of 399) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 399 results.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinomaLorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Medicinal Chemistry|December 28, 2020
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell DiseaseAriamala Gopalsamy, Ann E Aulabaugh, Amey Barakat, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Gastroenterology|December 24, 2021
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug DevelopmentTongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.
Hepatology (Baltimore, Md.)|February 21, 2024
Genome-wide association study identifies high-impact susceptibility loci for HCC in North AmericaManal M Hassan, Donghui Li, Younghun Han, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Pageof 40

Showing results (391-400 of 399) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 399 results.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinomaLorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Medicinal Chemistry|December 28, 2020
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell DiseaseAriamala Gopalsamy, Ann E Aulabaugh, Amey Barakat, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Gastroenterology|December 24, 2021
Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug DevelopmentTongqi Qian, Naoto Fujiwara, Bhuvaneswari Koneru, et al.
Hepatology (Baltimore, Md.)|February 21, 2024
Genome-wide association study identifies high-impact susceptibility loci for HCC in North AmericaManal M Hassan, Donghui Li, Younghun Han, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular CarcinomaNeehar D Parikh, Patricia Jones, Reena Salgia, et al.
Pageof 40